Retraction: CAR-NK Cell: a new paradigm in tumor immunotherapy
- 1Immunology Research Center (IRC), Tabriz University of Medical Sciences, Tabriz, Iran
- 2College of Medicine, University of Babylon, Babylon, Iraq
- 3College of Medicine, University of Sulaimani, Sulaymaniyah, Iraq
- 4Department of Medical Laboratory Sciences, Komar University of Science and Technology, Sulaymaniyah, Iraq
- 5Tyumen State Medical University, Tyumen, Russia
- 6Tyumen Industrial University, Tyumen, Russia
- 7Department of Health and Rehabilitation Sciences, College of Applied Medical Sciences, Prince Sattam bin Abdulaziz University, Al Kharj, Saudi Arabia
- 8Department of Physical Therapy, Kasr Al-Aini Hospital, Cairo University, Giza, Egypt
- 9Sechenov First Moscow State Medical University, Moscow, Russia
- 10Department of Biology, School of Basic Science, Science and Research Branch, Islamic Azad University, Tehran, Iran
- 11Department of Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
- 12Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA, United States
- 13DigiCare Behavioral Research, Casa Grande, AZ, United States
- 14German Cancer Research Center, Toxicology and Chemotherapy Unit (G401), Heidelberg, Germany
Citation: Marofi F, Al-Awad AS, Sulaiman Rahman H, Markov A, Abdelbasset WK, Ivanovna Enina Y, Mahmoodi M, Hassanzadeh A, Yazdanifar M, Stanley Chartrand M and Jarahian M (2021) CAR-NK Cell: A New Paradigm in Tumor Immunotherapy. Front. Oncol. 11:673276. doi: 10.3389/fonc.2021.673276
Received: 09 March 2021; Accepted: 14 May 2021;
Published: 10 June 2021; Retracted: 01 September 2023.
Edited by:
Rizwan Ronee, Dana–Farber Cancer Institute, United StatesReviewed by:
Evren Alici, Karolinska Institutet (KI), SwedenManisha Singh, University of Texas MD Anderson Cancer Center, United States